Cargando…
The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
BACKGROUND: Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH. METHODS: We conducted a long-term retrospective ob...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131314/ https://www.ncbi.nlm.nih.gov/pubmed/37098543 http://dx.doi.org/10.1186/s12890-023-02427-2 |
_version_ | 1785031150899560448 |
---|---|
author | Sonnweber, Thomas Tymoszuk, Piotr Steringer-Mascherbauer, Regina Sigmund, Elisabeth Porod-Schneiderbauer, Stephanie Kohlbacher, Lisa Theurl, Igor Lang, Irene Weiss, Günter Löffler-Ragg, Judith |
author_facet | Sonnweber, Thomas Tymoszuk, Piotr Steringer-Mascherbauer, Regina Sigmund, Elisabeth Porod-Schneiderbauer, Stephanie Kohlbacher, Lisa Theurl, Igor Lang, Irene Weiss, Günter Löffler-Ragg, Judith |
author_sort | Sonnweber, Thomas |
collection | PubMed |
description | BACKGROUND: Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH. METHODS: We conducted a long-term retrospective observational study (median follow-up: 67 months) including 183 PAH patients from three Austrian PAH expert centers. Clinical, cardiopulmonary function, laboratory, imaging, and hemodynamic parameters were assessed. Cox proportional hazard Elastic Net and partitioning around medoid clustering were applied to establish a multi-parameter PAH mortality risk signature and investigate PAH phenotypes. RESULTS: Seven parameters identified by Elastic Net modeling, namely age, six-minute walking distance, red blood cell distribution width, cardiac index, pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide and right atrial area, constituted a highly predictive mortality risk signature (training cohort: concordance index = 0.82 [95%CI: 0.75 – 0.89], test cohort: 0.77 [0.66 – 0.88]). The Elastic Net signature demonstrated superior prognostic accuracy as compared with five established risk scores. The signature factors defined two clusters of PAH patients with distinct risk profiles. The high-risk/poor prognosis cluster was characterized by advanced age at diagnosis, poor cardiac output, increased red cell distribution width, higher pulmonary vascular resistance, and a poor six-minute walking test performance. CONCLUSION: Supervised and unsupervised learning algorithms such as Elastic Net regression and medoid clustering are powerful tools for automated mortality risk prediction and clinical phenotyping in PAH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02427-2. |
format | Online Article Text |
id | pubmed-10131314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101313142023-04-27 The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial Sonnweber, Thomas Tymoszuk, Piotr Steringer-Mascherbauer, Regina Sigmund, Elisabeth Porod-Schneiderbauer, Stephanie Kohlbacher, Lisa Theurl, Igor Lang, Irene Weiss, Günter Löffler-Ragg, Judith BMC Pulm Med Research Article BACKGROUND: Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH. METHODS: We conducted a long-term retrospective observational study (median follow-up: 67 months) including 183 PAH patients from three Austrian PAH expert centers. Clinical, cardiopulmonary function, laboratory, imaging, and hemodynamic parameters were assessed. Cox proportional hazard Elastic Net and partitioning around medoid clustering were applied to establish a multi-parameter PAH mortality risk signature and investigate PAH phenotypes. RESULTS: Seven parameters identified by Elastic Net modeling, namely age, six-minute walking distance, red blood cell distribution width, cardiac index, pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide and right atrial area, constituted a highly predictive mortality risk signature (training cohort: concordance index = 0.82 [95%CI: 0.75 – 0.89], test cohort: 0.77 [0.66 – 0.88]). The Elastic Net signature demonstrated superior prognostic accuracy as compared with five established risk scores. The signature factors defined two clusters of PAH patients with distinct risk profiles. The high-risk/poor prognosis cluster was characterized by advanced age at diagnosis, poor cardiac output, increased red cell distribution width, higher pulmonary vascular resistance, and a poor six-minute walking test performance. CONCLUSION: Supervised and unsupervised learning algorithms such as Elastic Net regression and medoid clustering are powerful tools for automated mortality risk prediction and clinical phenotyping in PAH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02427-2. BioMed Central 2023-04-25 /pmc/articles/PMC10131314/ /pubmed/37098543 http://dx.doi.org/10.1186/s12890-023-02427-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Sonnweber, Thomas Tymoszuk, Piotr Steringer-Mascherbauer, Regina Sigmund, Elisabeth Porod-Schneiderbauer, Stephanie Kohlbacher, Lisa Theurl, Igor Lang, Irene Weiss, Günter Löffler-Ragg, Judith The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
title | The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
title_full | The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
title_fullStr | The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
title_full_unstemmed | The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
title_short | The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
title_sort | combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131314/ https://www.ncbi.nlm.nih.gov/pubmed/37098543 http://dx.doi.org/10.1186/s12890-023-02427-2 |
work_keys_str_mv | AT sonnweberthomas thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT tymoszukpiotr thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT steringermascherbauerregina thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT sigmundelisabeth thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT porodschneiderbauerstephanie thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT kohlbacherlisa thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT theurligor thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT langirene thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT weissgunter thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT lofflerraggjudith thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT sonnweberthomas combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT tymoszukpiotr combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT steringermascherbauerregina combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT sigmundelisabeth combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT porodschneiderbauerstephanie combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT kohlbacherlisa combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT theurligor combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT langirene combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT weissgunter combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial AT lofflerraggjudith combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial |